Last checked at 
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
--------
Animalcare Group PLC - York, England-based veterinary drug maker - Posts revenue of GBP38.3 million for the first six months of 2022, down slightly from GBP39.1 million the year before. However, pretax profit climbs to GBP3.4 million from GBP791,000 the year before. Declares an interim dividend of 2.0p per share, in line with prior year. Says first half of the year has faced "stiff headwinds", notable inflationary pressures and a moderation of the "exceptional" post-Covid-19 growth seen last year. Looking ahead, the company expects a revenue bias to the first half of the year compared to the second half. Adds that it pans to spend GBP500,000 over the full year on research & development.
--------
Silver Bullet Data Services Group PLC - London-based provider of digital transformation services and products - Post GBP2.3 million revenue for the first six months of 2022, up 40% from GBP1.7 million year-on-year and in line with market expectations. Headline pretax loss widens to GBP3.4 million from GBP3.0 million last year, however reported pretax loss narrows to GBP3.8 million from GBP3.9 million. Says headline results are calculated before exception items and share option charges. Chief Executive Ian James comments: "I am very pleased to report that Silverbullet has delivered solid results for the period, delivering significant revenue growth, adding substantial new clients, expanding further into the US and LatAm and continuing development of our 4D product and revenue stream." Looking ahead, the company says it has "material visibility" on full-year revenue, however it is not immune to the challenging macro-economic environment which may have a negative impact on marketing investment in the second half of the year and into 2023.
--------
Diaceutics PLC -Belfast-based testing laboratories company - Posts revenue of GBP7.5 million for the six months that ended on June 30, up 25% from GBP6.0 million a year earlier. Says more than 76% of revenue is generated through the company's DXRX platform. DXRX is a commercialisation platform used in the field of precision medicine, a field of healthcare where treatments are tailored for smaller groups or patients, rather than a one-drug-fits-all method. However, pretax loss widens to GBP1.1 million in the first six months of the year, compared to GBP537,000 the year before. Looking ahead, the company remains positive and expects to report full year results in line with expectations. Adds that its order book at June 30 amounts to GBP10.2 million, compared to GBP1.7 million at the end of December. Expects GBP3.8 million of the order booked to realised in the second half of the year, with GBP4.1 million in 2023 and GBP2.3 million in 2024 & future years. "Continued investment in our platform business alongside our dedication to both platform adoption and customer migration has enabled Diaceutics to progress faster and farther than anticipated, with our customer adoption timeline currently a year ahead of plan," says Chief Executive & Founder Peter Keeling.
--------
ECSC Group PLC - Bradford, Yorkshire-based cybersecurity firm - Posts GBP2.8 million revenue for first half of 2022, down 8% from GBP3.0 million the year before. Notes that revenue from Managed Detection & Response division was down 16% to GBP1.2 million, from GBP1.5 million, due to pipeline issues caused by Covid-19 pandemic. Loss before tax widens to GBP784,000 from GBP302,000 the year before. Chief Executive Matthew Briggs says: "H1 was a challenging period, however, we have a firm handle on what caused the under performance. Some changes have already been implemented. With several more tactical and strategic initiatives now identified and being executed, I am expecting to see improvements in H2 with further improvements during 2023."
--------
By Sophie Rose; sophierose@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
